It will be interesting to know if these bacterial infections, or even sub-clinical bacterial infections, are sufficient to drive NLRC4-inflammasome activation via direct renal infection or circulating bacterial products like flagellin. The gene discussed is NLRC4; the disease is bacterial infectious disease.